AAAAAA

   
Results: 1-8 |
Results: 8
CD34 AUGMENTATION IMPROVES ALLOGENEIC T-CELL-DEPLETED BONE-MARROW ENGRAFTMENT
Authors: NOGA SJ SEBER A DAVIS JM BERENSON RJ VOGELSANG GB BRAINE HG HESS AD MARCELLUS D MILLER CA SHARKIS SJ GOODMAN SN SANTOS GW JONES RJ
Citation: Sj. Noga et al., CD34 AUGMENTATION IMPROVES ALLOGENEIC T-CELL-DEPLETED BONE-MARROW ENGRAFTMENT, Journal of hematotherapy, 7(2), 1998, pp. 151-157
CHEMOTHERAPY DOES NOT NULLIFY THE ABILITY OF DONOR LYMPHOCYTE INFUSIONS TO MEDIATE GRAFT-VERSUS-HOST REACTIONS
Authors: FUCHS EJ SEBER A ALTOMONTE V BRAINE HG HUMPHREY RL JONES RJ NOGA SJ SCHEPERS K WRIGHT SK VOGELSANG GB
Citation: Ej. Fuchs et al., CHEMOTHERAPY DOES NOT NULLIFY THE ABILITY OF DONOR LYMPHOCYTE INFUSIONS TO MEDIATE GRAFT-VERSUS-HOST REACTIONS, Bone marrow transplantation, 22(3), 1998, pp. 303-305
CD34(-CELL AUGMENTATION OF ALLOGENEIC, ELUTRIATED MARROW GRAFTS IMPROVES ENGRAFTMENT BUT CYCLOSPORINE-A IS STILL REQUIRED TO REDUCE GVHD AND MORBIDITY() STEM)
Authors: NOGA SJ VOGELSANG GB SEBER A DAVIS JM SCHEPERS K HESS AD JONES RJ
Citation: Sj. Noga et al., CD34(-CELL AUGMENTATION OF ALLOGENEIC, ELUTRIATED MARROW GRAFTS IMPROVES ENGRAFTMENT BUT CYCLOSPORINE-A IS STILL REQUIRED TO REDUCE GVHD AND MORBIDITY() STEM), Transplantation proceedings, 29(1-2), 1997, pp. 728-732
UNEXPLAINED EFFUSIONS - ASSOCIATION WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION AND ACUTE OR CHRONIC GRAFT-VERSUS-HOST DISEASE
Authors: SEBER A KHAN SP KERSEY JH
Citation: A. Seber et al., UNEXPLAINED EFFUSIONS - ASSOCIATION WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION AND ACUTE OR CHRONIC GRAFT-VERSUS-HOST DISEASE, Bone marrow transplantation, 17(2), 1996, pp. 207-211
DONOR LEUKOCYTE INFUSIONS (DLI) FOR THE TREATMENT OF RELAPSED HEMATOLOGICAL MALIGNANCIES AFTER ALLOGENEIC ELUTRIATED BONE-MARROW TRANSPLANTATION (BMT)
Authors: SEBER A NOGA SJ HARRIS D HATTENBURG C FUCHS EJ
Citation: A. Seber et al., DONOR LEUKOCYTE INFUSIONS (DLI) FOR THE TREATMENT OF RELAPSED HEMATOLOGICAL MALIGNANCIES AFTER ALLOGENEIC ELUTRIATED BONE-MARROW TRANSPLANTATION (BMT), Blood, 88(10), 1996, pp. 1030-1030
DO INDIVIDUAL GRAFT PARAMETERS INFLUENCE ENGRAFTMENT OR GVHD IN PATIENTS RECEIVING ELUTRIATED CD34+ AUGMENTED ALLOGRAFTS/
Authors: ODONNELL PV NOGA SJ VOGELSANG GB SEBER A SCHEPERS K DAVIS JM JONES RJ
Citation: Pv. Odonnell et al., DO INDIVIDUAL GRAFT PARAMETERS INFLUENCE ENGRAFTMENT OR GVHD IN PATIENTS RECEIVING ELUTRIATED CD34+ AUGMENTED ALLOGRAFTS/, Blood, 88(10), 1996, pp. 1670-1670
TRANSIENT LEUKOCYTE SLUMP - A COMMON OCCURRENCE AFTER ALLOGENEIC BMT
Authors: SEBER A ZAHURAK ML NOGA SJ JONES RJ GOODMAN SN VOGELSANG GB
Citation: A. Seber et al., TRANSIENT LEUKOCYTE SLUMP - A COMMON OCCURRENCE AFTER ALLOGENEIC BMT, Blood, 86(10), 1995, pp. 395-395
THE INCIDENCE OF GVHD, BUT NOT ENGRAFTMENT IS AFFECTED BY CYCLOSPORINE-A (CSA) DURATION FOLLOWING TRANSPLANTATION WITH CD34+ AUGMENTED ELUTRIATED (A/E) MARROW/
Authors: NOGA SJ VOGELSANG GB SEBER A CHEN AR JONES RJ
Citation: Sj. Noga et al., THE INCIDENCE OF GVHD, BUT NOT ENGRAFTMENT IS AFFECTED BY CYCLOSPORINE-A (CSA) DURATION FOLLOWING TRANSPLANTATION WITH CD34+ AUGMENTED ELUTRIATED (A/E) MARROW/, Blood, 86(10), 1995, pp. 1566-1566
Risultati: 1-8 |